HK2 and neoplasm: 2-DG is a small-molecule HK2 inhibitor that competitively inhibits HK2-mediated glucose phosphorylation, weakens the immunosuppressive network and macrophage polarization, enhances anti-tumor immunity, and contributes to local tumor control in mouse models (69).